|
|
Volumn 21, Issue 1, 2009, Pages 1-5
|
|
Top-up Payments in Cancer Care
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
BORTEZOMIB;
CETUXIMAB;
ERLOTINIB;
LAPATINIB;
LENALIDOMIDE;
PANITUMUMAB;
PEMETREXED;
SORAFENIB;
SUNITINIB;
BREAST CANCER;
CANCER RADIOTHERAPY;
COLON CANCER;
DRUG RESEARCH;
EDITORIAL;
FINANCIAL MANAGEMENT;
GASTROINTESTINAL STROMAL TUMOR;
HEALTH CARE ACCESS;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HEALTH CARE FINANCING;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HEALTH INSURANCE;
HUMAN;
INDIVIDUALIZATION;
INTENSITY MODULATED RADIATION THERAPY;
KIDNEY CANCER;
LIVER CANCER;
LUNG CANCER;
MALIGNANT NEOPLASTIC DISEASE;
MESOTHELIOMA;
MYELOMA;
NATIONAL HEALTH SERVICE;
PANCREAS CANCER;
PATIENT CARE;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
PRIVATE PRACTICE;
UNITED KINGDOM;
FINANCING, PERSONAL;
GREAT BRITAIN;
HEALTH CARE COSTS;
HEALTH EXPENDITURES;
HUMANS;
NEOPLASMS;
PRIVATE SECTOR;
STATE MEDICINE;
|
|
EID: 58149149744
PISSN: 09366555
EISSN: None
Source Type: Journal
DOI: 10.1016/j.clon.2008.11.002 Document Type: Editorial |
|
Times cited : (5)
|
|
References (9)
|
